Singapore, Aug. 11 -- South Korea-based Hugel Inc., a leading global medical aesthetics company, has officially launched its botulinum toxin product Letybo inMalaysia- an emerging market for medical aesthetics inSoutheast Asia.
The company's Malaysian partner Venusys Medical Sdn Bhd introduced Letybo at the Aesthetic Medicine & Surgery Conference & Exhibition (AMSC), the largest medical aesthetics conference inMalaysia, held fromAugust 6 to 7.
Konstantin Frank, a key opinion leader for Letybo inEurope, delivered a presentation at the event, highlighting the precise treatment outcomes of botulinum toxin procedures and sharing clinical strategies to enhance procedural results.
A brand launch event and hands-on workshop followed onAugust ...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.